A phase II trial of low-dose total body irradiation and subcutaneous Interleukin-2 in metastatic melanoma

Akmal Safwat, Henrik Schmidt, Lars Bastholt, Kirsten Fode, Susanne Larsen, Ninna Aggerholm, Hans von der Maase
  • Radiotherapy and Oncology, November 2005, Elsevier
  • DOI: 10.1016/j.radonc.2005.09.008
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Dr Ninna Aggerholm-Pedersen